AZD1152 in Patients With Advanced Solid Malignancies-Study 1

NCT00497731 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
70
Enrollment
INDUSTRY
Sponsor class

Stopped Efficacy seen in the solid tumour patient population was not sufficient to continue research with AZD1152 monotherapy in solid tumors at that time.

Conditions

Interventions

Sponsor

AstraZeneca